Murli Krishna Pharma: Vision & Mission for Anemia Mukt Bharat

Murli Krishna Pharma Pvt. Ltd., a leading pharmaceutical company in India, has set its sights on a noble mission: to contribute to the eradication of anemia in the country. With its innovative solutions and unwavering commitment to quality, Murli Krishna Pharma is poised to play a significant role in the government’s “Anemia Mukt Bharat” initiative.

At the heart of Murli Krishna Pharma’s vision lies a deep understanding of the challenges posed by anemia, a condition that affects millions of people, particularly women and children, across India. Recognizing the urgent need for effective interventions, the company has developed a groundbreaking Transdermal Lotion ( ) that offers a novel approach to treating anemia.

Transdermal Lotion: A Step Towards Anemia Mukht Bharat

The Transdermal Lotion, designed specifically for children suffering from malnutrition and anemia, works on the “6X6X6” strategy as suggested by the government authorities. This innovative solution, which is applied topically on the skin, has proven to be more effective than traditional oral pills in helping children recover from anemia.

Murli Krishna Pharma’s commitment to the “Anemia Mukt Bharat” mission is further demonstrated by their recent donation of the Transdermal Lotion by Dr. Satya Vadlamani, Chairperson and Managing Director of Murli Krishna Pharma, along with Dr. Vijay Shastri, Technical Director, to a leading hospital based in Mumbai. MKPPL plans to expand its reach to other healthcare facilities across the country, contributing to the eradication of anemia among children.

Leadership and Innovation: Dr. Satya Valdamani, CMD

Dr. Satya Vadlamani, CMD of Murli Krishna Pharma Pvt. Ltd., has demonstrated exemplary leadership in providing innovative solutions to combat anemia in India. Under Dr. Vadlamani’s guidance, Murli Krishna Pharma has developed a groundbreaking Transdermal Lotion specifically designed to treat anemia in children suffering from malnutrition.

Her commitment to the “Anemia Mukt Bharat” mission is further evident in his recent meeting with doctors of a leading hospital based in Mumbai and donating bottles of Transdermal Lotion. This gesture demonstrates Murli Krishna Pharma’s dedication to making its innovative solution accessible to those in need.

Dr. Satya Vadlamani’s vision and leadership have positioned Murli Krishna Pharma as a key player in the fight against anemia in India. Her unwavering commitment to improving the lives of children and communities nationwide is a testament to her dedication and the company’s mission to contribute to the “Anemia Mukt Bharat” initiative.

Affordable and Accessible: Transdermal Lotion 

Murli Krishna Pharma Pvt. Ltd. has pioneered the development of Transdermal Lotion as a branded formulation to combat anemia, focusing on affordability and accessibility. This innovative solution is designed to cater to treating anemia through a metered dose administration, aligning with the vision of the “Anemia Mukt Bharat” initiative. By leveraging solvent-free manufacturing processes, Murli Krishna Pharma ensures the production of high-quality products at affordable rates, making them accessible to a wider population in need of anemia treatment. The company’s commitment to providing world-class pharmaceutical solutions extends to ensuring that their Transdermal Lotion is not only effective but also cost-effective, addressing the challenge of accessibility in the fight against anemia in India. Through its dedication to quality and innovation, Murli Krishna Pharma is making significant strides in improving healthcare outcomes for individuals affected by anemia.

Quality and Standards 

Murli Krishna Pharma Pvt. Ltd. maintains a strong focus on quality and innovation in its fight against anemia, with its Transdermal Lotion. The company’s state-of-the-art manufacturing facilities have received approval from regulatory authorities in developed countries like the European Union and WHO. This recognition underscores Murli Krishna Pharma’s commitment to producing high-quality products that meet international standards.

By adhering to stringent quality control measures and utilizing advanced manufacturing processes, Murli Krishna Pharma ensures that its Transdermal Lotion for anemia treatment is safe, effective, and reliable. These state-of-the-art facilities not only enable the company to deliver innovative solutions but also demonstrate its dedication to providing cutting-edge pharmaceutical products to combat anemia and improve the health outcomes of individuals in need.